Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

NEW YORK, July 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

http://www.reportlinker.com/p0910506/Peripheral-Neuropathy-Sensory-Neuropathy-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

 

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

 

Summary

 

GlobalData's clinical trial report, "Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013" provides data on the Peripheral Neuropathy (Sensory Neuropathy) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Neuropathy (Sensory Neuropathy). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Neuropathy (Sensory Neuropathy). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

 

 

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 7

Introduction 8

Peripheral Neuropathy (Sensory Neuropathy) 8

Report Guidance 8

Clinical Trials by Region 9

Clinical Trials by Country 10

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by BRIC Nations 17

Clinical Trials by G7 Nations 18

Clinical Trials in G7 Nations by Trial Status 19

Clinical Trials by E7 Nations 21

Clinical Trials in E7 Nations by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Unaccomplished Trials of Peripheral Neuropathy (Sensory Neuropathy) 26

Subjects Recruited Over a Period of Time 30

Prominent Sponsors 31

Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 33

Prominent Drug Comparison 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

NeurogesX, Inc. 37

Clinical Trial Overview of NeurogesX, Inc. 37

GW Pharmaceuticals plc 38

Clinical Trial Overview of GW Pharmaceuticals plc 38

Johnson & Johnson 39

Clinical Trial Overview of Johnson & Johnson 39

CSL Behring LLC 40

Clinical Trial Overview of CSL Behring LLC 40

Origin BioMed, Inc. 41

Clinical Trial Overview of Origin BioMed, Inc. 41

Endo Pharmaceuticals Inc. 42

Clinical Trial Overview of Endo Pharmaceuticals Inc. 42

Protemix Corporation Limited 43

Clinical Trial Overview of Protemix Corporation Limited 43

Neurotune AG 44

Clinical Trial Overview of Neurotune AG 44

Eisai Inc. 45

Clinical Trial Overview of Eisai Inc. 45

Lupin Limited 46

Clinical Trial Overview of Lupin Limited 46

Merck KGaA 47

Clinical Trial Overview of Merck KGaA 47

Sigma-Tau S.p.A. 48

Clinical Trial Overview of Sigma-Tau S.p.A. 48

Bristol-Myers Squibb Company 49

Clinical Trial Overview of Bristol-Myers Squibb Company 49

Octapharma AG 50

Clinical Trial Overview of Octapharma AG 50

Laboratorios Del Dr. Esteve S.A. 51

Clinical Trial Overview of Laboratorios Del Dr. Esteve S.A. 51

Cubist Pharmaceuticals, Inc. 52

Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 52

Astellas Pharma Inc. 53

Clinical Trial Overview of Astellas Pharma Inc. 53

Grifols, S.A. 54

Clinical Trial Overview of Grifols, S.A. 54

Otsuka Pharmaceutical Co., Ltd. 55

Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 55

Clinical Trial Overview of Top Institutes / Government 56

The University of Texas M. D. Anderson Cancer Center 56

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56

Odense University Hospital 57

Clinical Trial Overview of Odense University Hospital 57

National Taiwan University Hospital 58

Clinical Trial Overview of National Taiwan University Hospital 58

The National Institute of Allergy and Infectious Diseases 59

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 59

National Center for Research Resources 60

Clinical Trial Overview of National Center for Research Resources 60

Washington University School of Medicine 61

Clinical Trial Overview of Washington University School of Medicine 61

Northwestern University 62

Clinical Trial Overview of Northwestern University 62

Erasmus MC 63

Clinical Trial Overview of Erasmus MC 63

Mayo Clinic 64

Clinical Trial Overview of Mayo Clinic 64

Johns Hopkins University 65

Clinical Trial Overview of Johns Hopkins University 65

Assistance Publique - Hopitaux de Paris 66

Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 66

The University of Auckland 67

Clinical Trial Overview of The University of Auckland 67

U.S. Department of Veterans Affairs 68

Clinical Trial Overview of U.S. Department of Veterans Affairs 68

National Center for Complementary and Alternative Medicine 69

Clinical Trial Overview of National Center for Complementary and Alternative Medicine 69

Oregon Health and Science University 70

Clinical Trial Overview of Oregon Health and Science University 70

Columbia University 71

Clinical Trial Overview of Columbia University 71

Virginia Commonwealth University 72

Clinical Trial Overview of Virginia Commonwealth University 72

Skane University Hospital 73

Clinical Trial Overview of Skane University Hospital 73

National Institute of Neurological Disorders and Stroke 74

Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 74

H. Lee Moffitt Cancer Center & Research Institute 75

Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 75

Five Key Clinical Profiles 76

Appendix 200

Abbreviations 200

Definitions 200

Research Methodology 201

Secondary Research 201

About GlobalData 202

Contact Us 202

Disclaimer 202

Source 203

 

List of Tables

 

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries, 2013* 14

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, BRIC Countries, 2013* 17

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, G7 Countries, 2013* 18

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 20

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, E7 Countries, 2013* 21

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Phase, 2013* 23

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 24

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Suspended Clinical Trials, 2013* 26

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 27

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Terminated Clinical Trials, 2013* 28

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 36

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by NeurogesX, Inc., 2013* 37

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2013* 38

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 39

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Behring LLC, 2013* 40

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Origin BioMed, Inc., 2013* 41

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2013* 42

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Protemix Corporation Limited, 2013* 43

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotune AG, 2013* 44

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2013* 45

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lupin Limited, 2013* 46

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2013* 47

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2013* 48

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 49

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2013* 50

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Del Dr. Esteve S.A., 2013* 51

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2013* 52

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 53

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2013* 54

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 55

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 56

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2013* 57

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 58

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 59

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 60

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 61

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 62

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2013* 63

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 64

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 65

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 66

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Auckland, 2013* 67

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 68

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2013* 69

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2013* 70

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2013* 71

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2013* 72

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2013* 73

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013* 74

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2013* 75

 

List of Figures

 

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, G7 Countries (%), 2013* 18

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, E7 Countries (%), 2013* 21

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 22

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 23

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 24

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 25

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33

Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35

GlobalData Methodology 201

 

 

 

To order this report:

Drug_Discovery_and_Development Industry: Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

 

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.